| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 11/07/2001 | EP1150979A1 Heteroaryl amidines, methylamidines and guanidines as protease inhibitors |
| 11/07/2001 | EP1150978A1 Carbamate derivatives of diaryl 1,3,4-oxadiazolone |
| 11/07/2001 | EP1150976A1 3-(thio-substituted amido)-lactams useful as inhibitors of matrix metalloproteinase |
| 11/07/2001 | EP1150974A1 Heterocyclic derivatives as inhibitors of factor xa |
| 11/07/2001 | EP1150973A1 Heteroaryl-substituted quinolin-2-one derivatives useful as anticancer agents |
| 11/07/2001 | EP1150970A1 (1-phenacy-3-phenyl-3-piperidylethyl)piperidine derivatives, method for the production thereof and pharmaceutical compositions containing the same |
| 11/07/2001 | EP1150969A1 Alpha-azacyclomethyl quinoline derivatives for treating urinary incontinence |
| 11/07/2001 | EP1150965A1 Benzazepine derivatives as alpha-v integrin receptor antagonists |
| 11/07/2001 | EP1150963A1 Substituted 4-amino-2-aryltetrahydroquinazolines, their preparation, their use and pharmaceutical compositions comprising them |
| 11/07/2001 | EP1150960A1 Polymorphic crystalline forms of celecoxib |
| 11/07/2001 | EP1150959A1 Solid-state form of celecoxib having enhanced bioavailability |
| 11/07/2001 | EP1150954A1 Anti-imflammatory indole derivatives |
| 11/07/2001 | EP1150953A1 Indole derivatives and their use as mcp-1 receptor antagonists |
| 11/07/2001 | EP1150950A2 Anthranilic acid derivatives |
| 11/07/2001 | EP1150948A1 ALKENYL AND ALKYNYL COMPOUNDS AS INHIBITORS OF FACTOR Xa |
| 11/07/2001 | EP1150746A2 The use of 4-h-1-benzopryan-4-one derivatives as inhibitors of smooth muscle cell proliferation |
| 11/07/2001 | EP1150680A1 Use of moxonidine for postmyocardial infarction treatment |
| 11/07/2001 | EP1150679A1 Use of cholesterol-lowering agent |
| 11/07/2001 | EP1150670A2 Alkylating agents for treatment of cellular proliferation |
| 11/07/2001 | EP1150669A1 L-arginine based formulations for treating diseases and methods of using same |
| 11/07/2001 | EP1150664A2 Novel use of orexin receptor antagonists |
| 11/07/2001 | EP1150661A2 Topical sprays comprising a film forming composition |
| 11/07/2001 | EP1150658A2 Method for controlling liposome size |
| 11/07/2001 | EP1150564A1 Inositol derivatives for inhibiting superoxide anion production |
| 11/07/2001 | EP0758452B1 Modulators of cytokines of the tgf-beta superfamily and methods for assaying for same |
| 11/07/2001 | EP0755265B1 The combination of growth hormone and insulin-like growth factor, for treating congestive heart failure |
| 11/07/2001 | EP0655996B1 Substituted benzylamino nitrogen containing non-aromatic heterocycles |
| 11/07/2001 | CN1321166A Propanolamine derivs. linked with bile acid used for treating disorders of lipid metabolism |
| 11/07/2001 | CN1321154A Propanolamine derivs. substd. with heteocyclic compound, methods for their production, pharmaceutical compositions contg. said compounds and use thereof |
| 11/07/2001 | CN1321152A Substd. oxazoles and thiazoles derivs. as hPPAR gamma and hPPAR alpha activators |
| 11/07/2001 | CN1321151A Chemical compounds |
| 11/07/2001 | CN1321150A Amide derivs. useful as inhibitors of production of cytokines |
| 11/07/2001 | CN1321149A New crystal modification III of torasemide |
| 11/07/2001 | CN1321148A Aryl-substd. propanolamine derivs., method for their production, medicaments contg. said compounds and their use |
| 11/07/2001 | CN1321090A Treatment of vascular restenosis |
| 11/07/2001 | CN1321088A sustained release ranolazine formulations |
| 11/07/2001 | CN1320689A Expression system using autotomy of fusion protein, and reduced polypeptide |
| 11/07/2001 | CN1320601A 6-amino or 6-hydrazino-sulfonyl-3-quinolyl phosphonic acid compound, preparing process thereof and pharmaceutical composition contg. same |
| 11/07/2001 | CN1320599A Limited 9-cis-isotretinoins |
| 11/07/2001 | CN1320452A Chinese medicine for treating heart disease |
| 11/07/2001 | CN1320449A Medicine for treating heart disease |
| 11/07/2001 | CN1320426A Compound for treatment of female sexual dysfuction |
| 11/07/2001 | CN1074412C Novel 2,4-dioxopyrrolidine and 2,4-dioxotetrahydrofuran derivs. and medicines contg. same as active ingredient |
| 11/07/2001 | CN1074284C Health-care tea with blood circulation promoting and blood pressure lowering effect, and method for preparing same |
| 11/06/2001 | US6313311 Imidazole derivatives having affinity for alpha2 receptors |
| 11/06/2001 | US6313308 Methods for the preparation of biphenyl isoxazole sulfonamides |
| 11/06/2001 | US6313298 Spiro-indolines as Y5 receptor antagonists |
| 11/06/2001 | US6313290 Azolobenzazepine derivatives and compositions and method of use thereof |
| 11/06/2001 | US6313270 DbpB |
| 11/06/2001 | US6313174 Aminobenzophenones as inhibitors of interleukin and TNF |
| 11/06/2001 | US6313171 Method for preventing or treating elevated blood lipid level-related diseases by administering cinnamic acid derivatives |
| 11/06/2001 | US6313164 Dithiolin derivatives, their preparation and their therapeutic effect |
| 11/06/2001 | US6313160 Substituted heterocyclic compounds, method for preparing and compositions containing same |
| 11/06/2001 | US6313156 Thiazole compounds as cyclic-AMP-specific phosphodiesterase inhibitors |
| 11/06/2001 | US6313146 Calcium receptor-active molecules |
| 11/06/2001 | US6313142 Method for making 4-carboxyamino-2-substituted-1,2,3,4-tetrahydroquinoline |
| 11/06/2001 | US6313140 Method of treatment using certain growth-hormone secret agogues |
| 11/06/2001 | US6313134 For therapy and prophylaxis of cardiac disease selected from the group consisting of cardiac arrhythmia, myocardial ischemia, myocardial infarction, sudden death caused by cardiac arrhythmiamyocardial infarction |
| 11/06/2001 | US6313118 Hydroxytryptamine receptor antagonists |
| 11/06/2001 | US6313117 Succinate derivative compounds useful as cysteine protease inhibitors |
| 11/06/2001 | US6313116 Phosphodiesterase inhibitors |
| 11/06/2001 | US6313109 Prenyl transferase inhibitors |
| 11/06/2001 | US6313107 Methods of providing and using compounds having activity as inhibitors of cytochrome P450RAI |
| 11/06/2001 | US6312898 Diagnosing and treating subjects having increased risk for the development of the disease using polymerase chain reaction and/or sequencing methods to determine amino acid polymorphism in the protein |
| 11/06/2001 | US6312753 Cocoa components, edible products having enriched polyphenol content, methods of making same and medical uses |
| 11/06/2001 | US6312689 Antibodies or antigens |
| 11/06/2001 | US6312686 Modulating the permeability of a physiological barrier with an agent that modulates tyrosine phosphorylation |
| 11/01/2001 | WO2001081622A2 Diagnosis of diseases associated with dna repair |
| 11/01/2001 | WO2001081590A2 Protein phosphatases |
| 11/01/2001 | WO2001081585A2 A thymus expressed human cytochrome p450 (p450tec) |
| 11/01/2001 | WO2001081573A1 Edg8 receptor, its preparation and use |
| 11/01/2001 | WO2001081562A1 Novel insulin/igf/relaxin family polypeptides and dnas thereof |
| 11/01/2001 | WO2001081540A2 Growth factor which acts through erb b-4 rtk |
| 11/01/2001 | WO2001081415A2 Parathyroid hormone and parathyroid hormone-related protein antagonists |
| 11/01/2001 | WO2001081363A1 Novel compounds |
| 11/01/2001 | WO2001081348A1 USE OF 5-THIO-, SULFINYL- AND SULFONYLPYRAZOLO[3,4-b]-PYRIDINES AS CYCLIN DEPENDENT KINASE INHIBITORS |
| 11/01/2001 | WO2001081346A2 Inhibitors of human phosphatidyl-inositol 3-kinase delta |
| 11/01/2001 | WO2001081340A2 Heterocycles that are inhibitors of impdh enzyme |
| 11/01/2001 | WO2001081338A1 Substituted sulfonylaminopyrimidines |
| 11/01/2001 | WO2001081336A1 Process for the synthesis of a known tetrazol derivative |
| 11/01/2001 | WO2001081335A1 Pyrimidine-sulfonamides having endothelin-antagonist activity |
| 11/01/2001 | WO2001081334A2 Cyclic amidine compounds and their use as alpha4beta2 nicotinic acetylcholine receptor ligands |
| 11/01/2001 | WO2001081328A2 Thiazolidinedione analogues and their use for the treatment of diabetes |
| 11/01/2001 | WO2001081326A1 Substituted 1-aza-2-imino-heterocycles and their use as nicotinic acetylcholine receptors activators |
| 11/01/2001 | WO2001081323A1 Benzoxazine and benzothiazine derivatives and the use thereof in medicaments |
| 11/01/2001 | WO2001081314A1 Naphthamidine urokinase inhibitors |
| 11/01/2001 | WO2001081312A2 Method of treatment using phenyl and biaryl derivatives as prostaglandin e inhibitors and compounds useful therefore |
| 11/01/2001 | WO2001081311A1 Substituted benzoic acid amides and use thereof for the inhibition of angiogenesis |
| 11/01/2001 | WO2001081310A1 1-aroyl-piperidinyl benzamidines |
| 11/01/2001 | WO2001081298A2 Cyclic carboxylic acids as integrin antagonists |
| 11/01/2001 | WO2001081295A1 Cyclohexylamine derivative as subtype selective nmda receptor antagonists |
| 11/01/2001 | WO2001080895A2 Methods and compositions for the treatment of cardiac indications |
| 11/01/2001 | WO2001080852A1 Compositions and therapies for hyperlipidaemia-associated disorders |
| 11/01/2001 | WO2001080847A2 Combination of carboxyalkylethers with antihypertensives and pharmaceutical use |
| 11/01/2001 | WO2001080825A2 Sustained release drug delivery devices, methods of use, and methods of manufacturing thereof |
| 11/01/2001 | WO2001044239A3 Biphenyl sulfonamides as dual angiotensin endothelin receptor antagonists |
| 11/01/2001 | WO2001042231A3 Polyhydroxystilbenes and stilbene oxides as antisoriatic agents and protein kinase inhibitors |
| 11/01/2001 | WO2001041762A3 Valdecoxib compositions |
| 11/01/2001 | WO2001041761A3 Valdecoxib compositions |
| 11/01/2001 | WO2001038311A3 Pyrimidine derivatives as selective inhibitors of cox-2 |